Viedoc eClinical Platform (EDC, ePRO, RTSM)

Viedoc Technologies is an eClinical software company headquartered in Uppsala, Sweden, founded in 2003 by technologists from the contract research community. It builds software that lets pharmaceutical sponsors, CROs and academic groups collect and manage clinical trial data without paper case report forms, with teams in Hanoi, Tokyo, Shanghai, Melbourne and Raleigh.

The Viedoc platform is split into Designer, Admin and Clinic applications so users can design, manage and run studies on a low-code basis. Core modules cover electronic data capture (EDC), ePRO, televisits, record sharing and eSignature, with add-ons for randomisation and trial supply management (RTSM), AI-assisted medical coding, AI features under Viedoc Vantage and an open API. The company reports about 8,000 studies, 140,000 users and 1.6 million participants in more than 75 countries.

• Electronic data capture: low-code eCRF design with edit checks and study versioning.
• ePRO and televisits: patient-reported outcomes and remote visits in the same platform.
• RTSM: randomisation and trial supply management as an add-on module.
• AI medical coding: AI-suggested codes that the study team approves one by one.
• Viedoc Vantage: AI features for data review and study oversight.
• Open API: integration service and API for connecting labs, safety and analytics systems.

Vietnamese CROs and hospital clinical research centres can run sponsor studies on a validated EDC instead of paper CRFs. Domestic pharmaceutical firms can manage bioequivalence and post-marketing studies with ePRO and RTSM. Universities and research institutes can use the platform for investigator-initiated trials.

Modular, study-based pricing with unlimited users and no per-seat fees, with hosting, backups, support and updates included. The company reports an average study build time of about 10 weeks and 99.99% uptime. It states a 100% pass rate for studies that faced FDA inspection. Support for 40+ languages helps multi-country trials in Asia.

Vietnam aims to become one of the leading clinical trial hubs in ASEAN, and sponsors are moving more multi-country studies to Southeast Asia for faster recruitment. Regulators and sponsors expect electronic, audit-ready data that meets ICH GCP and 21 CFR Part 11. Mid-sized CROs and hospitals in the region need EDC tools that are quick to set up and priced per study rather than per user.

Founded in 2003; headquartered in Uppsala, Sweden, with about 140 staff and offices in Hanoi (Vietnam), Tokyo, Shanghai, Melbourne and Raleigh. Philip McCrea was named CEO in May 2025. Partnered with A2 Healthcare on risk-based monitoring (2025). Launched the Viedoc Verified partner programme in 2025.